|
|
Contents |
|
|
|
Etiology & Pathogenesis
|
|
Integrative
Medicine
|
|
Overall Management
|
|
Prognosis
& Outcome
|
|
Treatment
|
|
|
|
|
Etiology & Pathogenesis
|
|
|
|
Fallon KB, Havlioglu N, Hamilton LH, Cheng TP, Carroll
SL
Constitutive activation of the neuregulin-1/erbB
signaling pathway promotes the proliferation of a human peripheral
neuroepithelioma cell line
J Neurooncol. 2004 Feb;66(3):273-84.
|
|
Matsuo M, Yoshida N, Zaitsu M, Ishii K, Hamasaki Y
Inhibition of
human glioma cell growth by a PHS-2 inhibitor, NS398, and a prostaglandin E
receptor subtype EP1-selective antagonist, SC51089
J Neurooncol. 2004 Feb;66(3):285-92.
|
|
|
Integrative
Medicine
|
|
|
|
Burzynski SR
The present
state of antineoplaston research (1)
Integr Cancer Ther. 2004 Mar;3(1):47-58.
|
|
|
Overall Management
|
|
|
|
Ars C, Duck L, Baurain JF, Moulin P, Duprez T,
Machiels JP
Unusual metastatic features
in a patient with concomitant malignant orbital melanoma and prostate
carcinoma
J Neurooncol. 2004 Feb;66(3):361-3.
|
|
Buhl R, Huang H, Hugo HH, Mehdorn HM
Ganglioneurocytoma of
the third ventricle
J Neurooncol. 2004 Feb;66(3):341-4.
|
|
Cenacchi G, Giangaspero F
Emerging
tumor entities and variants of CNS neoplasms
J Neuropathol
Exp Neurol. 2004
Mar;63(3):185-92.
|
|
Maiuri F, Cappabianca P, Del Basso De Caro M, Esposito
F
Single brain metastases of carcinoid tumors
J Neurooncol. 2004 Feb;66(3):327-32.
|
|
|
Prognosis
& Outcome
|
|
|
| |
Brown PD, Buckner JC, O'Fallon JR, Iturria NL, O'Neill BP, Brown
CA, Scheithauer BW, Dinapoli RP, Arusell RM, Curran WJ, Abrams R, Shaw EG
Importance
of baseline mini-mental state examination as a prognostic factor for patients
with low-grade glioma
Int J Radiat Oncol Biol Phys. 2004
May 1;59(1):117-25.
|
|
Cohen ZR, Suki D, Weinberg JS, Marmor E, Lang FF,
Gershenson DM, Sawaya R
Brain metastases in
patients with ovarian carcinoma: prognostic factors and outcome
J Neurooncol. 2004 Feb;66(3):313-25.
|
|
Fife KM, Colman MH, Stevens GN, Firth IC, Moon D, Shannon KF, Harman R,
Petersen-Schaefer K, Zacest AC, Besser M, Milton GW, McCarthy WH, Thompson JF
Determinants
of outcome in melanoma patients with cerebral metastases
J Clin Oncol. 2004 Apr 1;22(7):1293-300.
|
|
|
Treatment
|
|
|
| |
Aguiar D, Pazo R, Duran I, Terrasa J, Arrivi A,
Manzano H, Martin J, Rifa J
Toxic epidermal
necrolysis in patients receiving anticonvulsants and cranial irradiation:
a risk to consider
J Neurooncol. 2004 Feb;66(3):345-50.
|
|
Alba A. Brandes, Umberto
Basso, Michele Reni, Francesca Vastola, Alicia
Tosoni, Giovanna Cavallo, Luciano Scopece,
Andres J. Ferreri, Maria G. Panucci, Silvio
Monfardini, Mario Ermani
First-Line
Chemotherapy With Cisplatin Plus Fractionated Temozolomide in Recurrent
Glioblastoma Multiforme: A Phase II Study of the Gruppo Italiano
Cooperativo di Neuro-Oncologia
Journal of Clinical Oncology, Vol 22, No 9 (May 1), 2004: pp.
1598-1604.
|
|
Parker RJ, Fruehauf JP, Mehta R, Filka E, Cloughesy T
A prospective blinded
study of the predictive value of an extreme drug resistance assay in patients
receiving CPT-11 for recurrent glioma
J Neurooncol. 2004 Feb;66(3):365-75.
|
|
Sharma RR, Singh DP, Pathak A, Khandelwal N, Sehgal
CM, Kapoor R, Ghoshal S, Patel FD, Sharma SC
Local control of
high-grade gliomas with limited volume irradiation versus whole brain
irradiation
Neurol India. 2003 Dec;51(4):512-7.
|
|
Swennen MH, Bromberg JE,
Witkamp TD, Terhaard CH, Postma TJ, Taphoorn MJ
Delayed radiation
toxicity after focal or whole brain radiotherapy for low-grade glioma
J Neurooncol. 2004 Feb;66(3):333-9.
|
bottom
|